Jun 14, 2022 / 09:00PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
We'll get started. My name is Matt Sykes. I'm a life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Olink to California. Thank you very much for making the trip. We have Carl Raimond, the Chief Commercial Officer; and Oskar Hjelm, the Chief Financial Officer. Carl and Oskar, thanks for joining us today.
Carl Raimond - Olink Holding AB(publ)-Chief Commercial Officer
Thanks for having us.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe we'll start out and let you kind of set the stage first and talk about some of the key accomplishments over the past 6 to 12 months and then maybe just focus on some of the recent results and key opportunities over the course of this year that we should be aware of.
Carl Raimond - Olink Holding AB(publ)-Chief
Olink Holding AB (publ) at Goldman Sachs Global Healthcare Conference Transcript
Jun 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers